share_log

NeuroPace Maintains FY24 Revenue Guidance Of $73M-$77M, Est $75.205M

Benzinga ·  May 8 17:23

Gross margin to range between 72% and 74%, Total operating expenses to range between $80 million and $84 million, including approximately $12 million in stock-based compensation, a noncash expense.

The company extended the maturity date of term loan by one year to September 30, 2026.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment